Influence of first- and second-generation antipsychotics on anthropometric parameters of male psychiatric patients

被引:0
|
作者
Nkondo-Ndaba, Maseqhala P. [1 ,2 ]
Joubert, Pierre M. [1 ,2 ]
Ballyram, Theona [1 ,2 ]
van Rensburg, Charl Janse [3 ]
机构
[1] Univ Pretoria, Fac Hlth Sci, Sch Med, Dept Psychiat, Pretoria, South Africa
[2] Weskoppies Psychiat Hosp, Pretoria, South Africa
[3] MRC, Biostat Unit, Pretoria, South Africa
关键词
psychiatric patients; antipsychotics; BMI; waist circumference; waist-to-hip ratio; waist-to-height ratio; body measures; SEVERE MENTAL-ILLNESS; CARDIOVASCULAR-DISEASE; HIP CIRCUMFERENCE; RISK-FACTORS; PREVALENCE; MORTALITY; SCHIZOPHRENIA; ASSOCIATION; OBESITY; IMPACT;
D O I
10.4102/sajpsychiatry.v28i0.1772
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: The use of antipsychotic medication, particularly second generation antipsychotics (SGAs) is a major risk factor for cardiovascular disease in people with severe mental illness (SMI). Few studies have compared body measures of people with SMI taking first generation antipsychotics (FGAs) to those taking SGAs. Aim: We compare body measures between long-term male inpatients using either FGAs or SGAs. Setting: The study was conducted at Weskoppies Psychiatric Hospital, in Pretoria, Gauteng. Methods: A total of 30 patients were selected from a list of male inpatients and were included in our study. Each participant had the following anthropometric measures done and these were compared between the two groups: Waist circumference (WC), body mass index (BMI), waist to hip ratio (WHR), waist to height ratio (WHtR) and hip circumference (HC). Hospital records were used to record demographic variables, diagnosis, comorbid disease and psychotropic medication for each participant. Results: Participants in the FGA and SGA groups had similar body measures, resulting in similar BMI, WHR and WHtR. Participants had a mean HC of 100.5 cm, 95% confidence interval (CI) (97.68, 103.22). BMI ranged from 21.87 kg/m(2) to 37.65 kg/m(2), with an overall mean of 28.5 kg/m(2), 95% CI (26.69, 30.22). Participants had a mean WHtR of 0.59, 95% CI (0.56, 0.61). Participants had a mean WC of 100.6 cm and 95% CI (96.26, 104.87), and the mean WHR of both groups was 1.0. Conclusion: Participants using FGAs and SGAs had similar body measures, and these indicated that this sample of male inpatients with SMI is at high risk for CVD.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis
    Carbon, Maren
    Kane, John M.
    Leucht, Stefan
    Correll, Christoph U.
    WORLD PSYCHIATRY, 2018, 17 (03) : 330 - 340
  • [42] First- V. second-generation antipsychotics and risk for diabetes in schizophrenia:: systematic review and meta-analysis
    Smith, M.
    Hopkins, D.
    Peveler, R. C.
    Holt, R. I. G.
    Woodward, M.
    Ismail, K.
    BRITISH JOURNAL OF PSYCHIATRY, 2008, 192 (06) : 406 - 411
  • [43] META-ANALYSIS OF TARDIVE DYSKINESIA RATES IN RANDOMIZED CONTROLLED STUDIES COMPARING FIRST- TO SECOND-GENERATION ANTIPSYCHOTICS
    Carbon, Maren
    Hsieh, Cheng-Hsi
    Kane, John
    Correll, Christoph
    SCHIZOPHRENIA BULLETIN, 2017, 43 : S71 - S71
  • [44] Elevated mutation rates in the germ line of first- and second-generation offspring of irradiated male mice
    Barber, R
    Plumb, MA
    Boulton, E
    Roux, I
    Dubrova, YE
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) : 6877 - 6882
  • [45] Polysomnographic and Q-EEG Studies in Young and Elderly Normal Subjects Under First- and Second-Generation Antipsychotics
    Saletu, B.
    Anderer, P.
    Stanek, J.
    Nikzad, R.
    Tajmir-Riahi, A.
    Pintzinger, N.
    Saletu-Zyhlarz, G. M.
    NEUROPSYCHOBIOLOGY, 2008, 58 (3-4) : 228 - 228
  • [46] Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: A comparison of first- vs. second-generation antipsychotics
    Nakonezny, PA
    Byerly, MJ
    SCHIZOPHRENIA RESEARCH, 2006, 82 (01) : 107 - 114
  • [47] Arterial Stiffness in Patients Taking Second-generation Antipsychotics
    Findikli, Ebru
    Gokce, Mustafa
    Nacitarhan, Vedat
    Camkurt, Mehmet Akif
    Findikli, Huseyin Avni
    Kardas, Selcuk
    Sahin, Merve Cosgun
    Karaaslan, Mehmet Fatih
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2016, 14 (04) : 365 - 370
  • [48] Mortality in schizophrenia patients treated with second-generation antipsychotics
    Kelly, DL
    Wehring, H
    Love, RC
    McMahon, RP
    Yu, Y
    Conley, RR
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 41 - 41
  • [49] Weight Gain in Asian Patients on Second-generation Antipsychotics
    Mahendran, Rathi
    Hendricks, M.
    Chan, Yiong Huak
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2010, 39 (02) : 118 - 121
  • [50] Metabolic Monitoring of Patients Prescribed Second-Generation Antipsychotics
    Dhamane, Amol D.
    Martin, Bradley C.
    Brixner, Diana I.
    Hudson, Teresa J.
    Said, Qayyim
    JOURNAL OF PSYCHIATRIC PRACTICE, 2013, 19 (05) : 360 - 374